Aarti Drugs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
AARTIDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Drugs Limited has submitted a certificate from its Registrar and Share Transfer Agent, MUFG Intime India Private Limited, under SEBI's Regulation 74(5) for the quarter ended June 30, 2025. The certificate confirms that all share certificates received for dematerialisation during the quarter were duly verified, confirmed or rejected to the depositories, and the underlying securities have been listed on the stock exchanges. It also confirms that the physical certificates were mutilated and cancelled, and the depositories' names were entered in the register of members within the prescribed timelines. This is a routine quarterly compliance filing required from every listed company.
This is a routine regulatory compliance disclosure with no material impact on business, financials, or share price. It simply confirms that the company's share dematerialisation process is functioning normally.